Video

Gary Mervis on Putting Cancer on the "Front Burner"

Author(s):

​Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).

Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).

Besides the actual brain tumor, patients with GBM also deal with other neurological problems, which can affect the whole family. To ensure that no family goes through brain cancer alone, Mervis established the camp, where families can come together and support one another.

Also, Mervis believes that "it's about time we stand up and put cancer on the front burner." He hopes that one day, he will no longer have to attend funerals of people who died from the disease.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses